Stockreport

Viatris Gets FDA Nod for Generic Sandostatin, Shares Regulatory Updates [Yahoo! Finance]

Viatris Inc.  (VTRS) 
PDF These achievements outline the company's R&D progress in 2025. VTRS will continuously work with health bodies across the world to advance its pipeline further. The FD [Read more]